Purchase Order HHSN272201501161P

This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in New Jersey. The $7,402.06 firm fixed-price purchase order is for the preparation of plasmid DNA samples to support biomedical research.

Genscript has received numerous prime and subcontract awards from NIAID, the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), and other federal agencies. These contracts typically involve supplying customized biological products and services, such as gene synthesis, protein expression, and antibody production, to aid various research and development efforts, including rapid responses to emerging infectious disease threats like COVID-19, influenza, HIV, and Ebola.

This particular award does not have a set-aside designation. However, Genscript has received some small business set-aside contracts from NIH and USDA in the past. The company also holds a significant blanket purchase agreement with USDA's Animal and Plant Health Inspection Service (APHIS) to provide SARS-CoV-2 surrogate virus neutralization test kits and associated reagents to support the agency's animal disease monitoring and research efforts.